Time to check your inboxes! Just last week, we released Part 1 of our 2022 payer landscape report, Perspectives on Vertical Payers. It summarizes key drivers that lead the biggest payers to "go vertical,” describes vertical payer structures and the role of their healthcare services, and identifies their likely impact on manufacturers’ business landscape.
This report reflects our commitment to help our valued clients…
Payers are verticalizing to keep more revenues ‘in-house’ - our slide below features more insight on exactly why that is and how that affects the delivery of care:
Don’t hesitate to check out this report in our client portal and stay tuned next week for the release of Part 2, Vertical Payer Profiles, which delivers a deep dive into specifics about each of our country’s 6 largest vertical payers.
As always, please reach out with any comments or questions you have.
All the best...
-- HMP Market Access Insights Team
Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.
Cindy ChenAs Oncology pathway programs continue to become more prominent in the marketplace, manufacturers are being challenged to assess how influential a specific pathway is.
Daniel BuchenbergerIn the final part of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore emerging models for success in oncology practice economics.
Lee Blansett